• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Pharmaceutical Contract Development and Manufacturing Market Size, Status and Forecast 2020-2026

report cover
  • 2 June 2020
  • Medical Devices
  • 92 Pages
  • Report Code: 24LS-5147
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Pharmaceutical Ctract Development -MARKET ADVISORY SERVICES

This report focuses on the global Pharmaceutical Contract Development and Manufacturing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Contract Development and Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central and South America.


The key players covered in this study

  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • Lonza Group Ltd
  • Recipharm AB
  • Vetter Pharma International GMBH
  • FAMAR Health Care Services
  • AbbVie Inc.
  • Aenova Group
  • Consort Medical plc
  • Almac Group
  • Siegfried Holding AG
  • Boehringer Ingelheim International GmbH 
  • Evonik Industries AG


Market segment by Type, the product can be split into

  • Pharmaceutical Manufacturing Services
  • Biologics Manufacturing Services
  • Drug Development Services

Market segment by Application, split into

  • Big Pharma
  • Small Pharma
  • Generic Pharma
  • CRO


Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central and South America


The study objectives of this report are:

  • To analyze global Pharmaceutical Contract Development and Manufacturing status, future forecast, growth opportunity, key market and key players.
  • To present the Pharmaceutical Contract Development and Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central and South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.


In this study, the years considered to estimate the market size of Pharmaceutical Contract Development and Manufacturing are as follows:

  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical Contract Development and Manufacturing Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Pharmaceutical Manufacturing Services
1.4.3 Biologics Manufacturing Services
1.4.4 Drug Development Services
1.5 Market by Application
1.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Big Pharma
1.5.3 Small Pharma
1.5.4 Generic Pharma
1.5.5 CRO
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Contract Development and Manufacturing Industry Impact
1.6.1 How the Covid-19 is Affecting the Pharmaceutical Contract Development and Manufacturing Industry
1.6.1.1 Pharmaceutical Contract Development and Manufacturing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pharmaceutical Contract Development and Manufacturing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pharmaceutical Contract Development and Manufacturing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Pharmaceutical Contract Development and Manufacturing Market Perspective (2015-2026)
2.2 Pharmaceutical Contract Development and Manufacturing Growth Trends by Regions
2.2.1 Pharmaceutical Contract Development and Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmaceutical Contract Development and Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmaceutical Contract Development and Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmaceutical Contract Development and Manufacturing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Market Size
3.1.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmaceutical Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio
3.2.1 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Development and Manufacturing Revenue in 2019
3.3 Pharmaceutical Contract Development and Manufacturing Key Players Head office and Area Served
3.4 Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service
3.5 Date of Enter into Pharmaceutical Contract Development and Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2021-2026)

5 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Application (2015-2026)
5.1 Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)
5.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
6.2 Pharmaceutical Contract Development and Manufacturing Key Players in North America (2019-2020)
6.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
6.4 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
7.2 Pharmaceutical Contract Development and Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
7.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

8 China
8.1 China Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
8.2 Pharmaceutical Contract Development and Manufacturing Key Players in China (2019-2020)
8.3 China Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
8.4 China Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
9.2 Pharmaceutical Contract Development and Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
9.4 Japan Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
10.2 Pharmaceutical Contract Development and Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

11 India
11.1 India Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
11.2 Pharmaceutical Contract Development and Manufacturing Key Players in India (2019-2020)
11.3 India Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
11.4 India Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

12 Central and South America
12.1 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
12.2 Pharmaceutical Contract Development and Manufacturing Key Players in Central and South America (2019-2020)
12.3 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
12.4 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Thermo Fisher Scientific Inc.
13.1.1 Thermo Fisher Scientific Inc. Company Details
13.1.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
13.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Introduction
13.1.4 Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020))
13.1.5 Thermo Fisher Scientific Inc. Recent Development
13.2 Catalent, Inc.
13.2.1 Catalent, Inc. Company Details
13.2.2 Catalent, Inc. Business Overview and Its Total Revenue
13.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Introduction
13.2.4 Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
13.2.5 Catalent, Inc. Recent Development
13.3 Lonza Group Ltd
13.3.1 Lonza Group Ltd Company Details
13.3.2 Lonza Group Ltd Business Overview and Its Total Revenue
13.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Introduction
13.3.4 Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
13.3.5 Lonza Group Ltd Recent Development
13.4 Recipharm AB
13.4.1 Recipharm AB Company Details
13.4.2 Recipharm AB Business Overview and Its Total Revenue
13.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Introduction
13.4.4 Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
13.4.5 Recipharm AB Recent Development
13.5 Vetter Pharma International GMBH
13.5.1 Vetter Pharma International GMBH Company Details
13.5.2 Vetter Pharma International GMBH Business Overview and Its Total Revenue
13.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Introduction
13.5.4 Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
13.5.5 Vetter Pharma International GMBH Recent Development
13.6 FAMAR Health Care Services
13.6.1 FAMAR Health Care Services Company Details
13.6.2 FAMAR Health Care Services Business Overview and Its Total Revenue
13.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Introduction
13.6.4 FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
13.6.5 FAMAR Health Care Services Recent Development
13.7 AbbVie Inc.
13.7.1 AbbVie Inc. Company Details
13.7.2 AbbVie Inc. Business Overview and Its Total Revenue
13.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Introduction
13.7.4 AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
13.7.5 AbbVie Inc. Recent Development
13.8 Aenova Group
13.8.1 Aenova Group Company Details
13.8.2 Aenova Group Business Overview and Its Total Revenue
13.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Introduction
13.8.4 Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
13.8.5 Aenova Group Recent Development
13.9 Consort Medical plc
13.9.1 Consort Medical plc Company Details
13.9.2 Consort Medical plc Business Overview and Its Total Revenue
13.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Introduction
13.9.4 Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
13.9.5 Consort Medical plc Recent Development
13.10 Almac Group
13.10.1 Almac Group Company Details
13.10.2 Almac Group Business Overview and Its Total Revenue
13.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Introduction
13.10.4 Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
13.10.5 Almac Group Recent Development
13.11 Siegfried Holding AG
10.11.1 Siegfried Holding AG Company Details
10.11.2 Siegfried Holding AG Business Overview and Its Total Revenue
10.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Introduction
10.11.4 Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
10.11.5 Siegfried Holding AG Recent Development
13.12 Boehringer Ingelheim International GmbH 
10.12.1 Boehringer Ingelheim International GmbH  Company Details
10.12.2 Boehringer Ingelheim International GmbH  Business Overview and Its Total Revenue
10.12.3 Boehringer Ingelheim International GmbH  Pharmaceutical Contract Development and Manufacturing Introduction
10.12.4 Boehringer Ingelheim International GmbH  Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
10.12.5 Boehringer Ingelheim International GmbH  Recent Development
13.13 Evonik Industries AG
10.13.1 Evonik Industries AG Company Details
10.13.2 Evonik Industries AG Business Overview and Its Total Revenue
10.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Introduction
10.13.4 Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
10.13.5 Evonik Industries AG Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Pharmaceutical Contract Development and Manufacturing Key Market Segments

Table 2. Key Players Covered: Ranking by Pharmaceutical Contract Development and Manufacturing Revenue

Table 3. Ranking of Global Top Pharmaceutical Contract Development and Manufacturing Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Pharmaceutical Manufacturing Services

Table 6. Key Players of Biologics Manufacturing Services

Table 7. Key Players of Drug Development Services

Table 8. COVID-19 Impact Global Market: (Four Pharmaceutical Contract Development and Manufacturing Market Size Forecast Scenarios)

Table 9. Opportunities and Trends for Pharmaceutical Contract Development and Manufacturing Players in the COVID-19 Landscape

Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 11. Key Regions/Countries Measures against Covid-19 Impact

Table 12. Proposal for Pharmaceutical Contract Development and Manufacturing Players to Combat Covid-19 Impact

Table 13. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 14. Global Pharmaceutical Contract Development and Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026

Table 15. Global Pharmaceutical Contract Development and Manufacturing Market Size by Regions (2015-2020) (US$ Million)

Table 16. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2015-2020)

Table 17. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 18. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2021-2026)

Table 19. Market Top Trends

Table 20. Key Drivers: Impact Analysis

Table 21. Key Challenges

Table 22. Pharmaceutical Contract Development and Manufacturing Market Growth Strategy

Table 23. Main Points Interviewed from Key Pharmaceutical Contract Development and Manufacturing Players

Table 24. Global Pharmaceutical Contract Development and Manufacturing Revenue by Players (2015-2020) (Million US$)

Table 25. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players (2015-2020)

Table 26. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2019)

Table 27. Global Pharmaceutical Contract Development and Manufacturing by Players Market Concentration Ratio (CR5 and HHI)

Table 28. Key Players Headquarters and Area Served

Table 29. Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service

Table 30. Date of Enter into Pharmaceutical Contract Development and Manufacturing Market

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020) (Million US$)

Table 33. Global Pharmaceutical Contract Development and Manufacturing Market Size Share by Type (2015-2020)

Table 34. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2021-2026)

Table 35. Global Pharmaceutical Contract Development and Manufacturing Market Size Share by Application (2015-2020)

Table 36. Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020) (Million US$)

Table 37. Global Pharmaceutical Contract Development and Manufacturing Market Size Share by Application (2021-2026)

Table 38. North America Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2019-2020) (Million US$)

Table 39. North America Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2019-2020)

Table 40. North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020) (Million US$)

Table 41. North America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2015-2020)

Table 42. North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020) (Million US$)

Table 43. North America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2015-2020)

Table 44. Europe Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2019-2020) (Million US$)

Table 45. Europe Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2019-2020)

Table 46. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020) (Million US$)

Table 47. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Type (2015-2020)

Table 48. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020) (Million US$)

Table 49. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Application (2015-2020)

Table 50. China Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2019-2020) (Million US$)

Table 51. China Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2019-2020)

Table 52. China Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020) (Million US$)

Table 53. China Pharmaceutical Contract Development and Manufacturing Market Share by Type (2015-2020)

Table 54. China Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020) (Million US$)

Table 55. China Pharmaceutical Contract Development and Manufacturing Market Share by Application (2015-2020)

Table 56. Japan Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2019-2020) (Million US$)

Table 57. Japan Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2019-2020)

Table 58. Japan Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020) (Million US$)

Table 59. Japan Pharmaceutical Contract Development and Manufacturing Market Share by Type (2015-2020)

Table 60. Japan Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020) (Million US$)

Table 61. Japan Pharmaceutical Contract Development and Manufacturing Market Share by Application (2015-2020)

Table 62. Southeast Asia Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2019-2020) (Million US$)

Table 63. Southeast Asia Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2019-2020)

Table 64. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020) (Million US$)

Table 65. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Share by Type (2015-2020)

Table 66. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020) (Million US$)

Table 67. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Share by Application (2015-2020)

Table 68. India Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2019-2020) (Million US$)

Table 69. India Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2019-2020)

Table 70. India Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020) (Million US$)

Table 71. India Pharmaceutical Contract Development and Manufacturing Market Share by Type (2015-2020)

Table 72. India Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020) (Million US$)

Table 73. India Pharmaceutical Contract Development and Manufacturing Market Share by Application (2015-2020)

Table 74. Central and South America Key Players Pharmaceutical Contract Development and Manufacturing Revenue (2019-2020) (Million US$)

Table 75. Central and South America Key Players Pharmaceutical Contract Development and Manufacturing Market Share (2019-2020)

Table 76. Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020) (Million US$)

Table 77. Central and South America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2015-2020)

Table 78. Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020) (Million US$)

Table 79. Central and South America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2015-2020)

Table 80. Thermo Fisher Scientific Inc. Company Details

Table 81. Thermo Fisher Scientific Inc. Business Overview

Table 82. Thermo Fisher Scientific Inc. Product

Table 83. Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 84. Thermo Fisher Scientific Inc. Recent Development

Table 85. Catalent, Inc. Company Details

Table 86. Catalent, Inc. Business Overview

Table 87. Catalent, Inc. Product

Table 88. Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 89. Catalent, Inc. Recent Development

Table 90. Lonza Group Ltd Company Details

Table 91. Lonza Group Ltd Business Overview

Table 92. Lonza Group Ltd Product

Table 93. Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 94. Lonza Group Ltd Recent Development

Table 95. Recipharm AB Company Details

Table 96. Recipharm AB Business Overview

Table 97. Recipharm AB Product

Table 98. Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 99. Recipharm AB Recent Development

Table 100. Vetter Pharma International GMBH Company Details

Table 101. Vetter Pharma International GMBH Business Overview

Table 102. Vetter Pharma International GMBH Product

Table 103. Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 104. Vetter Pharma International GMBH Recent Development

Table 105. FAMAR Health Care Services Company Details

Table 106. FAMAR Health Care Services Business Overview

Table 107. FAMAR Health Care Services Product

Table 108. FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 109. FAMAR Health Care Services Recent Development

Table 110. AbbVie Inc. Company Details

Table 111. AbbVie Inc. Business Overview

Table 112. AbbVie Inc. Product

Table 113. AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 114. AbbVie Inc. Recent Development

Table 115. Aenova Group Business Overview

Table 116. Aenova Group Product

Table 117. Aenova Group Company Details

Table 118. Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 119. Aenova Group Recent Development

Table 120. Consort Medical plc Company Details

Table 121. Consort Medical plc Business Overview

Table 122. Consort Medical plc Product

Table 123. Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 124. Consort Medical plc Recent Development

Table 125. Almac Group Company Details

Table 126. Almac Group Business Overview

Table 127. Almac Group Product

Table 128. Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 129. Almac Group Recent Development

Table 130. Siegfried Holding AG Company Details

Table 131. Siegfried Holding AG Business Overview

Table 132. Siegfried Holding AG Product

Table 133. Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 134. Siegfried Holding AG Recent Development

Table 135. Boehringer Ingelheim International GmbH? Company Details

Table 136. Boehringer Ingelheim International GmbH? Business Overview

Table 137. Boehringer Ingelheim International GmbH? Product

Table 138. Boehringer Ingelheim International GmbH? Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 139. Boehringer Ingelheim International GmbH? Recent Development

Table 140. Evonik Industries AG Company Details

Table 141. Evonik Industries AG Business Overview

Table 142. Evonik Industries AG Product

Table 143. Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020) (Million US$)

Table 144. Evonik Industries AG Recent Development

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmaceutical Contract Development and Manufacturing Market Share by Type: 2020 VS 2026

Figure 2. Pharmaceutical Manufacturing Services Features

Figure 3. Biologics Manufacturing Services Features

Figure 4. Drug Development Services Features

Figure 5. Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2020 VS 2026

Figure 6. Big Pharma Case Studies

Figure 7. Small Pharma Case Studies

Figure 8. Generic Pharma Case Studies

Figure 9. CRO Case Studies

Figure 10. Pharmaceutical Contract Development and Manufacturing Report Years Considered

Figure 11. Global Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)

Figure 12. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions: 2020 VS 2026

Figure 13. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2021-2026)

Figure 14. Porter's Five Forces Analysis

Figure 15. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players in 2019

Figure 16. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2019

Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue in 2019

Figure 18. North America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. Europe Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. China Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. Japan Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. India Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. Central and South America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 26. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 27. Catalent, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 28. Catalent, Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 29. Lonza Group Ltd Total Revenue (US$ Million): 2019 Compared with 2018

Figure 30. Lonza Group Ltd Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 31. Recipharm AB Total Revenue (US$ Million): 2019 Compared with 2018

Figure 32. Recipharm AB Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 33. Vetter Pharma International GMBH Total Revenue (US$ Million): 2019 Compared with 2018

Figure 34. Vetter Pharma International GMBH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 35. FAMAR Health Care Services Total Revenue (US$ Million): 2019 Compared with 2018

Figure 36. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 37. AbbVie Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 38. AbbVie Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 39. Aenova Group Total Revenue (US$ Million): 2019 Compared with 2018

Figure 40. Aenova Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 41. Consort Medical plc Total Revenue (US$ Million): 2019 Compared with 2018

Figure 42. Consort Medical plc Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 43. Almac Group Total Revenue (US$ Million): 2019 Compared with 2018

Figure 44. Almac Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 45. Siegfried Holding AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 46. Siegfried Holding AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 47. Boehringer Ingelheim International GmbH? Total Revenue (US$ Million): 2019 Compared with 2018

Figure 48. Boehringer Ingelheim International GmbH? Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 49. Evonik Industries AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. Evonik Industries AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

Thermo Fisher Scientific Inc.

Catalent, Inc.

Lonza Group Ltd

Recipharm AB

Vetter Pharma International GMBH

FAMAR Health Care Services

AbbVie Inc.

Aenova Group

Consort Medical plc

Almac Group

Siegfried Holding AG

Boehringer Ingelheim International GmbH?

Evonik Industries AG

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3198

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase